Cytek Biosciences Q4 Earnings Call Highlights [Yahoo! Finance]
Cytek Biosciences, Inc. (CTKB)
Company Research
Source: Yahoo! Finance
and APAC, a 208-unit installed-base expansion to units, and product momentum (notably the Aurora Evo ) as recurring revenue reached of sales (+21% YoY). Profitability weakened: Q4 GAAP gross margin fell to and the company reported a Q4 net loss of $44.1 million that included a $38.1 million non-cash deferred tax valuation allowance; adjusted EBITDA for 2025 declined to $5.0 million from $22.4 million a year earlier. Balance sheet and outlook: Cytek ended 2025 with $261.5 million in cash, repurchased about $15.1 million of stock (~3.3M shares), and initiated 2026 revenue guidance of $205–212 million (constant currency) assuming improved U.S./EMEA conditions and continued service/reagent strength. Interested in Cytek Biosciences, Inc.? Here are five stocks we like better. Cytek Biosciences (NASDAQ:CTKB) reported fourth-quarter and full-year 2025 results on Wednesday, describing a return to growth in the back half of the year amid what management characterized as a challenging in
Show less
Read more
Impact Snapshot
Event Time:
CTKB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTKB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTKB alerts
High impacting Cytek Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
CTKB
News
- Cytek Biosciences Inc (CTKB) Q4 2025 Earnings Call Highlights: Record Revenue Amidst Challenges [Yahoo! Finance]Yahoo! Finance
- Cytek Biosciences, Inc. (CTKB) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook GlobeNewswire
- Cytek Biosciences to participate at the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]Yahoo! Finance
- Cytek Biosciences to participate at the TD Cowen 46th Annual Health Care ConferenceGlobeNewswire
CTKB
Earnings
- 2/26/26 - Miss
CTKB
Sec Filings
- 2/27/26 - Form S-8
- 2/26/26 - Form 10-K
- 2/26/26 - Form 8-K
- CTKB's page on the SEC website